What MERIDIAN BIOSCIENCE INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kenny John P. | Chief Executive Officer | Jan 31 | Disposition to Issuer · D | −267,651 | — | — | 0 |
| Kenny John P. | Chief Executive Officer | Jan 31 | Grant / award · A | +47,060 | — | — | 267,651 |
| Williams Felicia | Director | Jan 31 | Disposition to Issuer · D | −10,274 | — | — | 0 |
| Smith Julie Diana | Sr VP, Controller, PAO | Jan 31 | Disposition to Issuer · D | −25,600 | — | — | 0 |
| Smith Julie Diana | Sr VP, Controller, PAO | Jan 31 | Disposition to Issuer · D | −32,708 | — | — | 0 |
| Smith Julie Diana | Sr VP, Controller, PAO | Jan 31 | Grant / award · A | +2,648 | — | — | 32,708 |
| McIlwraith John | Director | Jan 31 | Disposition to Issuer · D | −21,724 | — | — | 0 |
| Anderson James M. | Director | Jan 31 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Anderson James M. | Director | Jan 31 | Disposition to Issuer · D | −28,224 | — | — | 0 |
| Weltzien Lourdes | Executive VP, Life Science | Jan 31 | Disposition to Issuer · D | −86,045 | — | — | 0 |
| Weltzien Lourdes | Executive VP, Life Science | Jan 31 | Grant / award · A | +7,945 | — | — | 86,045 |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | Jan 31 | Disposition to Issuer · D | −43,338 | — | — | 0 |
| Serafini-Lamanna Tony | Executive VP-Diagnostics | Jan 31 | Grant / award · A | +7,945 | — | — | 43,338 |
| Kitzmiller Andrew S. | Executive Vice President & CFO | Jan 31 | Disposition to Issuer · D | −19,473 | — | — | 0 |
| Kitzmiller Andrew S. | Executive Vice President & CFO | Jan 31 | Grant / award · A | +7,945 | — | — | 19,473 |
| Sazdanoff Catherine | Director | Jan 31 | Disposition to Issuer · D | −16,424 | — | — | 0 |
| Rice John McCune Jr. | Director | Jan 31 | Disposition to Issuer · D | −27,449 | — | — | 0 |
| Bihl Anthony P Iii | Director | Jan 31 | Disposition to Issuer · D | −15,408 | — | — | 0 |
| Ellingwood Dwight E | Director | Jan 31 | Disposition to Issuer · D | −17,290 | — | — | 0 |
| Anderson James M. | Director | Jan 06 | Exercise / conversion · M | +8,500 | $20.38 | +$173K | 28,224 |
Loading...